Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
  2. News
  3. antigen avidity
Show results for
Products
Companies
News
Downloads
Refine by
Date

Antigen Avidity Articles & Analysis

1 news found
First patient dosed in SCIB1 Phase 2 clinical trial

First patient dosed in SCIB1 Phase 2 clinical trial

This is achieved by delivering a DNA plasmid using Ichor’s TriGrid® 2.0 electroporation delivery device to enhance the uptake and presentation of cancer antigens to harness high avidity T cell responses. In a Phase 1/2 clinical trial, survival following SCIB1 monotherapy was superior to historical survival rates, with 14 of 16 resected patients ...

ByScancell

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you